/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
All three Indian pharma companies have initiated the recall due to quality concerns.
Indian pharmaceutical companies Aurobindo Pharma, Glenmark and Zydus are recalling their products in the US market owing to manufacturing issues, according to the US Food and Drug Administration (USFDA), ET reported.
The companies have initiated Class II recalls, which the USFDA defines as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
The US subsidiary of Aurobindo Pharma initiated its recall on 7 November, recalling more than 100,000 bottles of Cinacalcet tablets of varying strengths due to …
ADNOC’s strong numbers underline a strategy built on higher output, shipping gains and new routes that sidestep the risky Strait of Hormuz.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Peace talks bring relief to the Emirates, but there’s still a ways to go before full-scale recovery.
